<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158942">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01029691</url>
  </required_header>
  <id_info>
    <org_study_id>F022873</org_study_id>
    <secondary_id>1K23HL095739-01</secondary_id>
    <nct_id>NCT01029691</nct_id>
  </id_info>
  <brief_title>Study of Positive Airway Pressure in Preeclampsia to Reduce Blood Pressure</brief_title>
  <official_title>Use of PAP in Women With Pre-eclampsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify whether sleep-disordered breathing - as measured by
      overnight polysomnography - is associated with pre-eclampsia and to determine whether use of
      positive airway pressure can improve nocturnal blood pressure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nocturnal blood pressure</measure>
    <time_frame>Nocturnal blood pressure is measured at baseline and 1 week after PAP treatment.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnoses of hypertension</measure>
    <time_frame>Diagnoses of hypertension are obtained from medical records within 1-6 months after enrollment.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gestational age at delivery</measure>
    <time_frame>At delivery (within 6 months of enrollment).</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birth weight</measure>
    <time_frame>At delivery (within 6 months of enrollment)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NICU admission</measure>
    <time_frame>at delivery (within 6 months of enrollment)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>PreEclampsia</condition>
  <arm_group>
    <arm_group_label>Positive Airway Pressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Positive Airway Pressure</intervention_name>
    <description>Women will use positive airway pressure until delivery</description>
    <arm_group_label>Positive Airway Pressure</arm_group_label>
    <other_name>PAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with preeclampsia who receive care at the University of Michigan Hospitals

          -  Aged at least 14 years old.

          -  No current use of PAP therapy.

          -  Willing and able to provide informed consent.

        Exclusion Criteria:

          -  Current PAP therapy

          -  Any medical reason why PAP therapy may not be suitable (e.g., in patients with recent
             head trauma).

          -  Cognitively impaired and unable to understand informed consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louise M O'Brien, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>August 17, 2015</lastchanged_date>
  <firstreceived_date>December 8, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Louise O'Brien</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Sleep disordered breathing</keyword>
  <keyword>Preeclampsia</keyword>
  <keyword>Positive Airway Pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
